25 Aug 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212810
20 Sep 2024
// BUSINESSWIRE
16 Sep 2024
// BUSINESSWIRE
05 Aug 2024
// BUSINESSWIRE
22 Jul 2024
// BUSINESSWIRE
04 Mar 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-renewal-of-exclusive-distribution-agreement-for-evomela-in-china-301495624.html